Webinars

SCLC's webinar series is integral to the technical assistance provided by the SCLC. Nationally recognized smoking cessation experts offer the latest information related to smoking cessation (including effective interventions) for the general and the behavioral health populations.

The Goals of SCLC’s Webinar Series:

  • Provide training and technical assistance to raise awareness of the many benefits smoking cessation efforts and to increase understanding of effective smoking cessation strategies.
  • Implement or enhance existing tobacco cessation services using evidence-based practices.
  • Ensure that consumers and staff have access to smoking cessation services and supports to promote health and wellness.
  • Establish partnerships between behavioral health and nicotine cessation organizations to increase available tobacco cessation resources in communities. 

SCLC has over 45 webinars covering the latest topics on tobacco addiction and recovery.

Current Webinars

What’s Smoking Got to Do with It? Improving the Health of Priority Populations by Treating Tobacco Use

Speakers

H. Westley Clark, MD, JD, MPH, CAS, FASAM

Dean's Executive Professor of Public Health, Santa Clara University, Santa Clara, California and former Director of the Substance and Mental Health Services Administration’s Center for Substance Abuse Treatment

Dr. Westley Clark is the Dean’s Executive Professor of Public Health, Santa Clara University, Santa Clara, CA. He is the former Director of the Center for Substance Abuse Treatment under the Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services. Dr. Clark led the agency's efforts to provide effective and accessible treatment to all Americans with addictive disorders. Dr. Clark's areas of expertise include substance abuse treatment, methadone maintenance, pain management, dual diagnosis, psychopharmacology, anger management, and medical and legal issues. He is also a noted author, clinician, teacher and spokesperson in the field of addiction and forensic psychiatry.

Dr. Clark has received numerous awards for his contribution to the field of substance abuse treatment, including the 2008 President of the United States of America, Rank of Distinguished Executive in the Senior Executive Service Award in recognition of his personal commitment to excellence in government and public service. In 2003, he was honored with Presidential Rank of Meritorious Executive Award for his sustained superior accomplishments in management of programs of the United States Government and for noteworthy achievement of quality and efficiency in the public service. Dr. Clark was also awarded the 2008 John P. McGovern Award from the American Society of Addiction Medicine for his contributions toward increased understanding of the relationship between addiction and society.

Dr. Clark received his medical degree from the University of Michigan and his law degree from Harvard University Law School. Dr. Clark received his board certification from the American Board of Psychiatry and Neurology in psychiatry and sub-specialty certifications in addiction psychiatry. Dr. Clark is licensed to practice medicine in California, Maryland, Massachusetts and Michigan. He is also a member of the Washington, D.C., Bar Association.

Lula A. Beatty, PhD

Senior Director, Health Disparities, American Psychological Association

Lula Beatty, Ph.D., is the Senior Director, Health Disparities, American Psychological Association (APA). She is responsible for the development and implementation of APA’s strategic initiative on health disparities including the conceptualization of initiative goals and translation into programs and activities and the development of resources and collaborations to support initiative goals. Specific responsibilities include the management of two working groups on health disparities in boys and men and stress and health disparities and a dissemination project on tobacco health disparities. Until 2012 she served as Director of the Special Populations Office, Office of the Director, National Institute on Drug Abuse, NIH where she was responsible for the overall administration of diversity and health disparities programs such as the Diversity Supplement Program and the Seminar Series, an early-career research mentoring workshop, and special initiatives, e.g., Southern Africa Initiative and African Americans and criminal justice. Before joining NIDA, she was Director of Research at the Institute for Urban Affairs and Research, Howard University. An APA member, she is a Fellow in the Society of Women in Psychology and the Society for the Psychological Study of Ethnic Minority Issues, has served as President of the Section of the Psychology of Black Women and member of the Committee on Women in Psychology, and is a member of the executive committee of the Leadership Institute for Women in Psychology. She is also a member of the Association of Black Psychologists, the American Public Health Association, and Sisters of the Academy.

She received her B.A. from Lincoln University (PA) and her doctoral degree in psychology from Howard University.

Webinar Objectives

Smoking and tobacco health disparities disproportionately impact health priority populations evidenced in higher morbidity and mortality. Attending to other “major” or “primary” conditions without treating tobacco use can compromise long-term treatment effectiveness (e.g., drug therapies) or subject clients to greater problems related to untreated smoking. Healthcare providers need to provide screening, prevention, and treatment for tobacco use in these populations.

  • Discuss reasons professionals may not attend to smoking in health priority populations and the consequences of not attending to smoking

  • Identify and discuss evidence-based practices effective with health priority populations

  • Specify that behavioral health professionals routinely screen their clients, and treat or refer them to treatment

Upcoming Webinars

Big Marijuana -- Lessons from Big Tobacco

Webinar Objectives

  • Identify how the tobacco industry magnified product harm, prevalence, and public health burden
  • Explain the current health consequences of marijuana, and the potential impact of industrialization on marijuana harms